We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$424M
AUM Growth
+$18.8M
Cap. Flow
-$6.82M
Cap. Flow %
-1.61%
Top 10 Hldgs %
15.99%
Holding
311
New
46
Increased
58
Reduced
107
Closed
45

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.03M
2
MCD icon
McDonald's
MCD
+$757K
3
CL icon
Colgate-Palmolive
CL
+$417K
4
GLW icon
Corning
GLW
+$349K
5
WPC icon
W.P. Carey
WPC
+$342K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$990K
2
TIF
Tiffany & Co.
TIF
+$591K
3
ADBE icon
Adobe
ADBE
+$473K
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$431K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$429K

Sector Composition

Rank Sector Weight
1 Technology 18.53%
2 Industrials 16.81%
3 Healthcare 10.71%
4 Consumer Discretionary 7.02%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SC
201
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
$264K 0.06%
+11,303
New +$275K
SPY icon
202
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$260K 0.06%
807
-1,399
-63% -$431K
CM icon
203
Canadian Imperial Bank of Commerce
CM
$107B
$258K 0.06%
+6,192
New +$262K
DRI icon
204
Darden Restaurants
DRI
$22.5B
$254K 0.06%
+2,330
New +$264K
CAH icon
205
Cardinal Health
CAH
$53.4B
$252K 0.06%
+4,973
New +$257K
INGR icon
206
Ingredion
INGR
$6.38B
$243K 0.06%
+2,616
New +$220K
TJX icon
207
TJX Companies
TJX
$170B
$242K 0.06%
3,957
– –
IART icon
208
Integra LifeSciences
IART
$1.54B
$233K 0.06%
4,000
– –
XLK icon
209
State Street Technology Select Sector SPDR ETF
XLK
$115B
$230K 0.05%
5,010
+2
+0% +$86
MFC icon
210
Manulife Financial
MFC
$72.6B
$226K 0.05%
11,143
-399
-3% -$7.62K
BABA icon
211
Alibaba
BABA
$269B
$225K 0.05%
+1,060
New +$199K
BIP icon
212
Brookfield Infrastructure Partners
BIP
$18.8B
$225K 0.05%
7,560
– –
EW icon
213
Edwards Lifesciences
EW
$47.6B
$224K 0.05%
2,883
-819
-22% -$64K
ELV icon
214
Elevance Health
ELV
$81.9B
$201K 0.05%
+666
New +$183K
REKR icon
215
Rekor Systems
REKR
$83.8M
$107K 0.03%
28,136
-112,489
-80% -$281K
A icon
216
Agilent Technologies
A
$39.1B
– –
-3,726
Closed -$286K
ALGN icon
217
Align Technology
ALGN
$12B
– –
-1,226
Closed -$222K
BRKR icon
218
Bruker
BRKR
$9.2B
– –
-6,144
Closed -$270K
CIEN icon
219
Ciena
CIEN
$55.3B
– –
-6,745
Closed -$265K
CRM icon
220
Salesforce
CRM
$134B
– –
-1,761
Closed -$261K
CTRA
221
DELISTED
Coterra Energy
CTRA
– –
-11,061
Closed -$194K
DBX icon
222
Dropbox
DBX
$6.81B
– –
-14,341
Closed -$289K
EXEL icon
223
Exelixis
EXEL
$13.9B
– –
-12,906
Closed -$228K
FFIV icon
224
F5
FFIV
$22.1B
– –
-1,623
Closed -$228K
FTNT icon
225
Fortinet
FTNT
$112B
– –
-15,830
Closed -$243K
7 8
9
10 11

Similar funds

VFG
Victory Financial Group Austin, Texas $814M AUM 18.17% 1-Year Est. Return
KCP
Kera Capital Partners San Jose, California $815M AUM 46.39% 1-Year Est. Return
AR
Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return
CICI
Capital Investment Counsel Inc Raleigh, North Carolina $816M AUM 34.73% 1-Year Est. Return
UAG
United Advisor Group Cincinnati, Ohio $811M AUM 18.32% 1-Year Est. Return
PS
Portfolio Strategies Monsey, New York $811M AUM 28.91% 1-Year Est. Return
BC
Brio Consultants San Francisco, California $818M AUM 13.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Stanley-Laman Group's Q4 2019 Portfolio in Review

As of Q4 2019, Stanley-Laman Group held 311 positions worth $424M, up 4.6% from $405M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Stanley-Laman Group's Q4 2019 filing shows 46 new, 58 increased, 107 reduced and 45 closed positions. Its largest new stake was McDonald's: 3,817 shares worth $754K. The largest sale was Celgene Corp, an estimated $990K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Industrials and Healthcare.

  • Stanley-Laman Group's largest Q4 2019 buy was McDonald's: 3,817 shares worth $754K.
  • Stanley-Laman Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.03M increase.
  • Stanley-Laman Group's biggest Q4 2019 reduction was Tiffany & Co., cutting an estimated $591K.
  • Stanley-Laman Group fully exited Celgene Corp in Q4 2019, selling an estimated $990K.
  • Stanley-Laman Group's ten largest holdings make up 16% of its $424M portfolio in Q4 2019.
  • Stanley-Laman Group opened 46 new positions and closed 45 in Q4 2019.
  • Stanley-Laman Group's portfolio value rose 4.6% quarter-over-quarter to $424M.

Based on Stanley-Laman Group's 13F filing for Q4 2019, filed 4 Feb 2020.